| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 141 |
| 1 | SECUKINUMAB | 141 |
| 2 | METHOTREXATE SODIUM | 92 |
| 3 | METHOTREXATE | 78 |
| 4 | ETANERCEPT | 68 |
| 5 | LEFLUNOMIDE | 40 |
| 6 | RISANKIZUMAB-RZAA | 38 |
| 7 | SULFASALAZINE | 37 |
| 8 | NAPROXEN | 30 |
| 9 | NAPROXEN SODIUM | 30 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CANNABIS SATIVA | 4 | 0.0048 |
| 1 | FLURANDRENOLIDE | 1 | 0.0039 |
| 2 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | 7 | 0.0026 |
| 3 | SODIUM FUSIDATE | 1 | 0.0018 |
| 4 | COAL TAR | 1 | 0.0018 |
| 5 | ACITRETIN | 6 | 0.0016 |
| 6 | NASAL SPRAY | 1 | 0.0016 |
| 7 | BETAMETHASONE DIPROPIONATE | 6 | 0.0014 |
| 8 | TILDRAKIZUMAB-ASMN | 1 | 0.0014 |
| 9 | MEBENDAZOLE | 1 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-17A Antagonist [EPC] | 148 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 100 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 78 |
| 3 | Interleukin-23 Antagonist [EPC] | 70 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 61 |
| 5 | Corticosteroid [EPC] | 48 |
| 6 | Antirheumatic Agent [EPC] | 40 |
| 7 | Aminosalicylate [EPC] | 37 |
| 8 | Interleukin-12 Antagonist [EPC] | 28 |
| 9 | Benzodiazepine [EPC] | 24 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17A Antagonist [EPC] | 148 | 0.0009 |
| 1 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0008 |
| 2 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 9 | 0.0005 |
| 3 | Interleukin-23 Antagonist [EPC] | 70 | 0.0005 |
| 4 | Antirheumatic Agent [EPC] | 40 | 0.0004 |
| 5 | Anthelmintic [EPC] | 1 | 0.0004 |
| 6 | Interleukin-12 Antagonist [EPC] | 28 | 0.0003 |
| 7 | Aminosalicylate [EPC] | 37 | 0.0003 |
| 8 | Chloride Channel Activator [EPC] | 2 | 0.0002 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 78 | 0.0002 |